Understanding the Differences in Toxicity Between Morphine and Its Metabolite
Author Information
Author(s): D. Hucks, P.I. Thompson, L. McLoughlin, S.P. Joel, N. Patel, A. Grossman, L.H. Rees, M.L. Slevin
Primary Institution: St Bartholomew's Hospital, London
Hypothesis
Morphine 6-glucuronide has a lower affinity for the mu 2 receptor than morphine, which may explain its reduced toxicity.
Conclusion
The study found that morphine 6-glucuronide has a significantly lower binding affinity for the mu 2 opioid receptor compared to morphine, which may account for its reduced respiratory depression and gastrointestinal side effects.
Supporting Evidence
- Morphine 6-glucuronide has a 4-fold lower affinity for the mu 2 receptor compared to morphine.
- The mu 2 receptor is thought to mediate respiratory depression and gastrointestinal effects.
- Less respiratory depression and nausea were observed in humans after administering morphine 6-glucuronide.
Takeaway
This study looked at how two forms of a pain medicine, morphine and morphine 6-glucuronide, work in the body. It found that the second form is less likely to cause breathing problems.
Methodology
The study used radiolabelled binding studies on homogenised rat brain preparations to determine the binding affinities of morphine and morphine 6-glucuronide at various opioid receptors.
Limitations
The study was conducted on rat brain preparations, which may not fully represent human physiology.
Statistical Information
P-Value
0.01
Statistical Significance
p=0.01
Want to read the original?
Access the complete publication on the publisher's website